MLchartDataset catalogue

anti-CD22 immunotoxin

Term · Oncology and biomedicine · MLC-T-ONC-000596

A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.

Table 1. Record
IdentifierMLC-T-ONC-000596
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000596",
  "term": "anti-CD22 immunotoxin",
  "field": "Oncology and biomedicine",
  "definition": "A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD22 immunotoxin is made in the laboratory. It binds to CD22, a protein on the surface of normal B cells and B-cell tumors, and kills the cells.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-cd22-immunotoxin/"
}

Record 1,395 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.